PHE has undertaken assessments of inactivation methods against SARS-CoV-2 with further evaluations ongoing.
Follow this news feed:
May42021
PHE has undertaken assessments of inactivation methods against SARS-CoV-2 with further evaluations ongoing.
Follow this news feed: